Cargando…

Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes

BACKGROUND: Early evidence-based medical interventions to improve patient outcomes after traumatic brain injury (TBI) are lacking. In patients admitted to the ICU after TBI, optimization of nutrition is an emerging field of interest. Specialized enteral nutrition (EN) formulas that include immunonut...

Descripción completa

Detalles Bibliográficos
Autores principales: Poblete, Roy A., Pena, Jesus E., Kuo, Grace, Tarzi, Fawaz, Nguyen, Peggy L., Cen, Steven Y., Yaceczko, Shelby, Louie, Stan G., Lewis, Meghan R., Martin, Matthew, Amar, Arun P., Sanossian, Nerses, Sung, Gene, Lyden, Patrick D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659558/
https://www.ncbi.nlm.nih.gov/pubmed/37986931
http://dx.doi.org/10.21203/rs.3.rs-3548036/v1
_version_ 1785148340352057344
author Poblete, Roy A.
Pena, Jesus E.
Kuo, Grace
Tarzi, Fawaz
Nguyen, Peggy L.
Cen, Steven Y.
Yaceczko, Shelby
Louie, Stan G.
Lewis, Meghan R.
Martin, Matthew
Amar, Arun P.
Sanossian, Nerses
Sung, Gene
Lyden, Patrick D.
author_facet Poblete, Roy A.
Pena, Jesus E.
Kuo, Grace
Tarzi, Fawaz
Nguyen, Peggy L.
Cen, Steven Y.
Yaceczko, Shelby
Louie, Stan G.
Lewis, Meghan R.
Martin, Matthew
Amar, Arun P.
Sanossian, Nerses
Sung, Gene
Lyden, Patrick D.
author_sort Poblete, Roy A.
collection PubMed
description BACKGROUND: Early evidence-based medical interventions to improve patient outcomes after traumatic brain injury (TBI) are lacking. In patients admitted to the ICU after TBI, optimization of nutrition is an emerging field of interest. Specialized enteral nutrition (EN) formulas that include immunonutrition containing omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been developed and are used for their proposed anti-inflammatory and pro-immune properties; however, their use has not been rigorously studied in human TBI populations. METHODS: A single-center, retrospective, descriptive observational study was conducted at LAC + USC Medical Center. Patients with severe TBI (sTBI, Glasgow Coma Scale score ≤ 8) who remained in the ICU for ≥ 2 weeks and received EN were identified between 2017 and 2022 using the institutional trauma registry. Those who received immunonutrition formulas containing n-3 PUFAs were compared to those who received standard, polymeric EN in regard to baseline characteristics, clinical markers of inflammation and immune function, and short-term clinical outcomes. RESULTS: A total of 151 patients with sTBI were analyzed. Those who received immunonutrition with n-3 PUFA supplementation were more likely to be male, younger, Hispanic/Latinx, and have polytrauma needing non-central nervous system surgery. No differences in clinical markers of inflammation or infection rate were found. In multivariate regression analysis, immunonutrition was associated with reduced hospital length of stay (LOS). ICU LOS was also reduced in the subgroup of patients with polytrauma and TBI. CONCLUSION: This study identifies important differences in patient characteristics and outcomes associated with the EN formula prescribed. Study results can directly inform a prospective pragmatic study of immunonutrition with n-3 PUFA supplementation aimed to confirm the biomechanistic and clinical benefits of the intervention.
format Online
Article
Text
id pubmed-10659558
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-106595582023-11-20 Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes Poblete, Roy A. Pena, Jesus E. Kuo, Grace Tarzi, Fawaz Nguyen, Peggy L. Cen, Steven Y. Yaceczko, Shelby Louie, Stan G. Lewis, Meghan R. Martin, Matthew Amar, Arun P. Sanossian, Nerses Sung, Gene Lyden, Patrick D. Res Sq Article BACKGROUND: Early evidence-based medical interventions to improve patient outcomes after traumatic brain injury (TBI) are lacking. In patients admitted to the ICU after TBI, optimization of nutrition is an emerging field of interest. Specialized enteral nutrition (EN) formulas that include immunonutrition containing omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been developed and are used for their proposed anti-inflammatory and pro-immune properties; however, their use has not been rigorously studied in human TBI populations. METHODS: A single-center, retrospective, descriptive observational study was conducted at LAC + USC Medical Center. Patients with severe TBI (sTBI, Glasgow Coma Scale score ≤ 8) who remained in the ICU for ≥ 2 weeks and received EN were identified between 2017 and 2022 using the institutional trauma registry. Those who received immunonutrition formulas containing n-3 PUFAs were compared to those who received standard, polymeric EN in regard to baseline characteristics, clinical markers of inflammation and immune function, and short-term clinical outcomes. RESULTS: A total of 151 patients with sTBI were analyzed. Those who received immunonutrition with n-3 PUFA supplementation were more likely to be male, younger, Hispanic/Latinx, and have polytrauma needing non-central nervous system surgery. No differences in clinical markers of inflammation or infection rate were found. In multivariate regression analysis, immunonutrition was associated with reduced hospital length of stay (LOS). ICU LOS was also reduced in the subgroup of patients with polytrauma and TBI. CONCLUSION: This study identifies important differences in patient characteristics and outcomes associated with the EN formula prescribed. Study results can directly inform a prospective pragmatic study of immunonutrition with n-3 PUFA supplementation aimed to confirm the biomechanistic and clinical benefits of the intervention. American Journal Experts 2023-11-07 /pmc/articles/PMC10659558/ /pubmed/37986931 http://dx.doi.org/10.21203/rs.3.rs-3548036/v1 Text en https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/) https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Poblete, Roy A.
Pena, Jesus E.
Kuo, Grace
Tarzi, Fawaz
Nguyen, Peggy L.
Cen, Steven Y.
Yaceczko, Shelby
Louie, Stan G.
Lewis, Meghan R.
Martin, Matthew
Amar, Arun P.
Sanossian, Nerses
Sung, Gene
Lyden, Patrick D.
Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes
title Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes
title_full Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes
title_fullStr Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes
title_full_unstemmed Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes
title_short Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes
title_sort immunonutrition with omega-3 fatty acid supplementation in severe tbi: retrospective analysis of patient characteristics and outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659558/
https://www.ncbi.nlm.nih.gov/pubmed/37986931
http://dx.doi.org/10.21203/rs.3.rs-3548036/v1
work_keys_str_mv AT pobleteroya immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT penajesuse immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT kuograce immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT tarzifawaz immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT nguyenpeggyl immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT censteveny immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT yaceczkoshelby immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT louiestang immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT lewismeghanr immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT martinmatthew immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT amararunp immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT sanossiannerses immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT sunggene immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes
AT lydenpatrickd immunonutritionwithomega3fattyacidsupplementationinseveretbiretrospectiveanalysisofpatientcharacteristicsandoutcomes